Cervical cancer rates stable or trending down in countries with effective screening measures

A recent trend analysis indicates that cervical cancer incidence and mortality rates have remained stable or are dropping in most countries across the globe. These rates differ based on each country’s socioeconomic development level, cervical cancer screening use, and human papillomavirus (HPV) vaccination rates. The findings are published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Cervical cancer is a potentially preventable disease, through screening to detect and treat precancerous lesions and through vaccination against HPV. To reveal the most recent global patterns and trends of cervical cancer, a team led by Mingjuan Jin, PhD, of the Zhejiang University School of Medicine in China, examined information released by the International Agency for Research on Cancer pertaining to 31 countries.

The researchers found that cervical cancer incidence and mortality rates were lower in more socioeconomically developed countries. Also, both past and predicted trends appear to be stable or decreasing in most countries, especially in those with effective cervical cancer screening and HPV vaccination programs.

Over the most recent 10 years, 12 countries had stable cervical cancer incidence rates, 14 had decreasing rates, and five had increasing rates. In terms of mortality from cervical cancer, 12 countries had stable rates, 18 had decreasing rates, and one had an increased rate.

In predictions over the next 15 years for 27 countries, most are expected to have stable or decreasing trends. Ten are predicted to have stable incidence rates, nine to have decreasing rates, and eight to have increasing rates. For mortality from cervical cancer, 16 are predicted to have stable rates, 10 to have decreasing rates, and one to have an increasing rate.

“Effective cervical cancer screening programs and HPV vaccination should be further popularized to increase their coverage and ultimately decrease cervical cancer’s short-, mid-, and long-term burden,” said Dr. Jin.

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com
Follow us on Twitter @WileyNews

Full Citation:

“Worldwide trends in cervical cancer incidence and mortality, with predictions to future 15 years.” Shujuan Lin, Kai Gao, Simeng Gu, Liuqing You, Sangni Qian, Mengling Tang, Jianbing Wang, Kun Chen, and Mingjuan Jin. CANCER; Published Online: August 9, 2021 (DOI: 10.1002/cncr.33795).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.33795

Author Contact: Dr. Mingjuan Jin, of the Zhejiang University School of Medicine, at jinmj@zju.edu.cn

About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.

Follow us on Twitter @JournalCancer

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.